Upper gastrointestinal bleeding · adults with cirrhosis and gastroesophageal varices
It is very uncertain whether carvedilol changes upper gastrointestinal bleeding compared with traditional, non‐selective beta‐blockers (very low certainty).
1 finding from 1 review
Serious adverse events · adults with cirrhosis and gastroesophageal varices
Carvedilol showed no clear difference in serious adverse events compared with traditional, non‐selective beta‐blockers (low certainty).
1 finding from 1 review
Non‐serious adverse events · adults with cirrhosis and gastroesophageal varices
It is very uncertain whether carvedilol changes non‐serious adverse events compared with traditional, non‐selective beta‐blockers (very low certainty).
1 finding from 1 review
Hepatic venous pressure gradient at end of treatment (mmHg) · adults with cirrhosis and gastroesophageal varices
1 finding from 1 review
Reduction in hepatic venous pressure gradient (%) · adults with cirrhosis and gastroesophageal varices
1 finding from 1 review
Haemodynamic treatment failure · adults with cirrhosis and gastroesophageal varices
It is very uncertain whether carvedilol changes haemodynamic treatment failure compared with traditional, non‐selective beta‐blockers (very low certainty).
1 finding from 1 review
Mortality due to all causes ‐ not reported · people with implantable ventricular assist devices
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality ‐ not measured · people with implantable ventricular assist devices
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rehospitalisation due to cardiovascular event ‐ not reported · people with implantable ventricular assist devices
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events: infection · people with implantable ventricular assist devices
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · people with implantable ventricular assist devices
1 finding from 1 review
Heart transplantation ‐ not reported · people with implantable ventricular assist devices
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Costs ‐ not reported · people with implantable ventricular assist devices
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Re‐establishment of oral intake (technical success of the intervention) · people with malignant gastric outlet obstruction
Duodenal stenting showed no clear difference in re‐establishment of oral intake (technical success of the… compared with surgical palliation (low certainty).
1 finding from 1 review
Time to re‐establishment of oral intake · people with malignant gastric outlet obstruction
Duodenal stenting showed no clear difference in time to re‐establishment of oral intake compared with surgical palliation (low certainty).
1 finding from 1 review
All‐cause mortality · people with malignant gastric outlet obstruction
It is very uncertain whether duodenal stenting changes all‐cause mortality compared with surgical palliation (very low certainty).
1 finding from 1 review
Median survival postintervention · people with malignant gastric outlet obstruction
It is very uncertain whether duodenal stenting changes median survival postintervention compared with surgical palliation (very low certainty).
1 finding from 1 review
Time to recurrence of obstructive symptoms · people with malignant gastric outlet obstruction
Duodenal stenting showed no clear difference in time to recurrence of obstructive symptoms compared with surgical palliation (moderate certainty).
1 finding from 1 review
Adverse events · people with malignant gastric outlet obstruction
It is very uncertain whether duodenal stenting changes adverse events compared with surgical palliation (very low certainty).
1 finding from 1 review
Length of hospital stay · people with malignant gastric outlet obstruction
Duodenal stenting showed no clear difference in length of hospital stay compared with surgical palliation (moderate certainty).
1 finding from 1 review